跳转至内容
Merck
CN
  • Photodynamic therapy in patients with head and neck squamous cell carcinoma.

Photodynamic therapy in patients with head and neck squamous cell carcinoma.

Lasers in surgery and medicine (2018-02-06)
Seiji Hosokawa, Satoru Takebayashi, Goro Takahashi, Jun Okamura, Hiroyuki Mineta
摘要

Photodynamic therapy (PDT) is a minimally invasive treatment for malignant tumors. The aim of this study was to determine the efficacy of PDT in patients with head and neck squamous cell carcinoma (HNSCC). Thirty-three patients with HNSCC were treated with porfimer sodium-mediated PDT followed by intraoperative light activation at 630 nm via fiber optic microlens delivered after 48 hours of injection. The complete response (CR) rate was 72.7%, while the efficacy (CR + partial response) rate was 97.0%. The rate of good local control (i.e., CR without recurrence after PDT) achieved after the initial PDT (82.6%) was significantly higher than that achieved after the second or third PDT (10%); this rate remained at 62.1% without functional disturbance and disfigurement even after excluding four previously untreated patients. The final local control rate following PDT plus additional therapies was 73.8%. PDT is an effective therapy to treat HNSCC, and leads to an improved quality of life in patients with residual or recurrent disease. Lasers Surg. Med. 50:420-426, 2018. © 2018 Wiley Periodicals, Inc.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
3-(2-吡啶基)-5,6-二苯基-1,2,4-三嗪, ≥99%